1 / 10

The Quality System (QS) Train is Moving Fast at FDA

The Quality System (QS) Train is Moving Fast at FDA. Lana L. Pauls, MPH Director, Quality Management Staff CDER/FDA. Learning Objectives At the conclusion of this session, participants should be able to:. Summarize the basic concepts of a quality system

shaw
Download Presentation

The Quality System (QS) Train is Moving Fast at FDA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The Quality System (QS) Train is Moving Fast at FDA Lana L. Pauls, MPH Director, Quality Management Staff CDER/FDA

  2. Learning ObjectivesAt the conclusion of this session, participants should be able to: • Summarize the basic concepts of a quality system • Describe the basic areas that FDA is implementing a QS • Discuss the detailed progress that FDA has made in regard to using a QS in three specific areas: • CBER • CDER/CBER - QMS for CMC • CDER - QMS impact on drug safety

  3. What is a Quality System? • In a nutshell . . . • Say what you do • Do what you say • Prove it • Improve it

  4. Why a QS? • Helps organize workflow • Helps prioritize resources • Minimizes employee frustration • Minimizes Industry frustration • Has been expected of Industry for many years • It just makes sense!

  5. Why Now? • PDUFA 3 Mandate • In the FDA strategic plan

  6. What Has Happened? • QS Framework developed in 2004 • SMG 2020 being used broadly across FDA (albeit slowly) • FDA Quality Resource and Guidance Team (QRGT) • Agency-level group of quality experts that provides: • resource materials and guidance • recommendations to the Management Council • Agency-wide implementation plans and communications

  7. Scope of QS Implementation at FDA (1) • Regulatory laboratory accreditation • CGMP initiative: • Recalls of pharmaceutical product • Warning letters related to CGMP issues • FDA pharmaceutical inspectorate • Process analytical technology (PAT) team • Team Biologics quality program

  8. Scope of QS Implementation at FDA (2) • Innovations in medicine: • Pre-approval review • Bioresearch monitoring (BIMO) • FDA Office of Management • IT Enterprise Architecture • PDUFA III Business/IT Governance

  9. PDUFA 3 QS Contracts • PDUFA 3 set aside for “Performance Excellence” • Nine contracts awarded to date • Postmarketing Commitments • Meeting Minutes • OND Process Improvement • OCPB Process Improvement • Quality System for CMC • OSE Process Improvement • Managerial costing (completed) • Evaluation of DSOB • Quality system training (completed)

  10. Presenters Deborah Jansen • “What Do You Mean When You Say Quality System: A CBER Perspective” Jon Clark Lana Pauls • “QMS: The Impact on the Drug Safety Process”

More Related